Medicount Deka Hematology Analyzer
510(k) K942525
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK942525 | Date5 Jun 1996 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- GKZ
- Device Class
- Class II
- Regulation
- 21 CFR Part 864.5220
- Advisory Committee
- Hematology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The Medicount Deka Hematology Analyzer is an automated differential cell counter, designed to identify and analyze formed elements of the blood. It performs automated counting, classification, and flagging of mature and immature hematopoietic cells, including abnormal cells, to support hematological diagnostics. This device is categorized under the FDA’s classification for automated differential cell counters, specifically under regulation number 864.5220.
The analyzer is intended for use in clinical laboratory settings, where it processes blood samples to generate differential counts and hematological parameters. Supplied as a reusable device, it requires proper maintenance and calibration to ensure accurate and reliable performance. The Medicount Deka Hematology Analyzer holds an FDA 510(k) clearance (K942525), confirming its regulatory compliance for automated hematological analysis. No specific MRI safety or sterility requirements are noted in the available data.
Other devices from Cea America Corp.
Questions
AI-generated answers, 1 Oct 2026
What is the Medicount Deka Hematology Analyzer used for?
The Medicount Deka Hematology Analyzer is designed for automated counting, classification, and flagging of mature and immature hematopoietic cells in blood samples. It supports hematological diagnostics by identifying and analyzing formed blood elements, including abnormal cells, to assist clinicians in diagnosing conditions like anemia, infections, or malignancies. This functionality is critical for accurate differential cell counts in clinical laboratory settings.
Is the Medicount Deka Hematology Analyzer reusable or single-use?
The Medicount Deka Hematology Analyzer is a reusable device. Like other automated hematology analyzers, it requires regular maintenance, calibration, and cleaning to ensure consistent performance and accuracy over time. Reusability helps reduce waste and operational costs in clinical settings.
Does the Medicount Deka Hematology Analyzer require any special storage conditions?
The device data does not specify special storage conditions beyond standard environmental requirements for medical equipment. It should be stored in a clean, dry environment, protected from extreme temperatures, humidity, and direct sunlight. Proper maintenance and calibration procedures should also be followed to preserve functionality, as outlined in the manufacturer’s instructions.
What regulatory approval does the Medicount Deka Hematology Analyzer hold?
The Medicount Deka Hematology Analyzer holds an FDA 510(k) clearance (K942525), confirming it is substantially equivalent to a legally marketed predicate device for automated differential cell counters. This clearance is specific to its intended use in clinical laboratories for hematological analysis. No additional regulatory details regarding sterility or MRI safety are mentioned in the available data.
How does the Medicount Deka Hematology Analyzer differ from other hematology analyzers?
The Medicount Deka Hematology Analyzer is distinguished by its automated capability to classify and flag both mature and immature hematopoietic cells, including abnormal cells, which aids in comprehensive hematological diagnostics. It falls under FDA classification 864.5220 for automated differential cell counters and has been cleared via a traditional 510(k) pathway. While other analyzers may focus on specific cell types or parameters, this device’s design emphasizes broad differential analysis for clinical decision-making.